drugset
drugset / Trial / NCT01188499

Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors

NCT01188499 ↗

Phase 1/2 Completed 176 enrolled TetraLogic Pharmaceuticals
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This is a dose escalation safety study of birinapant (TL32711) in combination with chemotherapy in subjects with advanced or metastatic solid tumors.

Timeline

Start
2010-10
Primary completion
2013-10
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Birinapant Small molecule — Intravenous

Indications

cancer